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Received 9 November 2009; received in revised form 24 March 2010; accepted 20 April 2010Abstract Understanding the complex mechanisms that govern the fate decisions of human embryonic stem cells
(hESCs) is fundamental to their use in cell replacement therapies. The progress of dissecting these mechanisms will be
facilitated by the availability of robust high-throughput screening assays on hESCs. In this study, we report an image-
based high-content assay for detecting compounds that affect hESC survival or pluripotency. Our assay was designed to
detect changes in the phenotype of hESC colonies by quantifying multiple parameters, including the number of cells in
a colony, colony area and shape, intensity of nuclear staining, and the percentage of cells in the colony that express a
marker of pluripotency (TRA-1-60), as well as the number of colonies per well. We used this assay to screen 1040
compounds from two commercial compound libraries, and identified 17 that promoted differentiation, as well as 5 that
promoted survival of hESCs. Among the novel small compounds we identified with activity on hESC are several steroids
that promote hESC differentiation and the antihypertensive drug, pinacidil, which affects hESC survival. The analysis of
overlapping targets of pinacidil and the other survival compounds revealed that activity of PRK2, ROCK, MNK1, RSK1,
and MSK1 kinases may contribute to the survival of hESCs.
© 2010 Elsevier B.V. All rights reserved.Introduction
The derivation of human embryonic stem cell (hESC) lines
opened up exciting opportunities for their use in regen-
erative medicine, as hESCs can be maintained in culture in
an undifferentiated state, while retaining the ability to
differentiate into somatic cell types (Thomson et al.,
1998). Delineating the molecular mechanisms that govern⁎ Corresponding author. Fax: +44 114 222 2399.
E-mail address: P.W.Andrews@sheffield.ac.uk (P.W. Andrews).
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doi:10.1016/j.scr.2010.04.006hESC self-renewal and differentiation to specific cell types
is critical to achieving the potential therapeutic benefits
of hESCs. Bioactive small molecules have proven to be
powerful probes for elucidating mechanisms underlying
various cellular processes (Kawasumi and Nghiem, 2007).
The use of small molecules in cell-based phenotype
screens provides an unbiased way of dissecting relevant
cellular pathways as this approach involves looking for a
change in the cell phenotype followed by analysis to
identify molecular targets within the cell (Chen et al.,
2006).
Some small compounds have already been successfully
applied for controlling stem cell fates. Examples include a.
105Human embryonic stem cellRho-kinase inhibitor, Y-27632, which promotes survival of
dissociated hESCs (Watanabe et al., 2007), pluripotin, which
promotes self-renewal of murine embryonic stem cells
(mESCs) (Chen et al., 2006), and stauprimide, which
enhances the directed differentiation of ESCs (Zhu et al.,
2009). Identifying further compounds that can modulate
various aspects of hESC biology would be beneficial for
improving hESC culture conditions, as well as for con-
trolling differentiation to desired cell types. Yet only a
small number of high-throughput (HTS) screens have been
performed on hESCs (Desbordes et al., 2008; Damoiseaux et
al., 2009). A further shortcoming has been that as hESC
growth characteristics are not readily amenable to HTS
setups, the published screens required significant adapta-
tion of hESCs to make them compatible with the HTS
methodologies used, namely, assessing cells in a monolayer
rather than in their normal colony morphology. Such
screens would inevitably lose potentially valuable informa-
tion about changes occurring in cultures after treatment
with compounds.
We have developed a high-content phenotype screen
that can detect multiple effects of small molecules on
hESCs in their natural in vitro state—as colonies. Our
screening platform combined automated imaging and
analysis, enabling quantitative assessment of the pheno-
type in a high-throughput fashion. We report the identifi-
cation of several novel compounds that affected hESC
survival and pluripotency.Results
Development of a high-content assay for hESCs
We developed an image-based high-content assay using the
InCell Analyzer (GE Healthcare) automated microscopy
system. The assay was designed to measure changes in
morphological features of hESC colonies as well as changes in
their pluripotency status. To detect changes in hESC
pluripotency, we utilized the cell-surface marker TRA-1-60,
which is down-regulated on differentiation (Andrews et al.,
1984; Draper et al., 2002). First, we validated our assay using
all-trans retinoic acid, a small molecule known to induce
differentiation of hESCs (Draper et al., 2002; Schuldiner et
al., 2000). Shef4 hESCs were dissociated to single cells using
Accutase and plated in 96-well plates in the presence of
10 µM all-trans retinoic acid or 0.1% DMSO (vehicle) as
control. After 5 days of treatment, the cells were fixed,
treated with Hoechst 33342 to highlight nuclei, and stained
for TRA-1-60 expression. A reduction in TRA-1-60 expression
and morphological changes were seen in Shef4 colonies
(Supplementary Fig. S1).Figure 1 High-content screening assay of hESC colonies. (a) Auto
96-well plate for (b) Hoechst 33342 fluorescence (staining nuclei o
TRA-1-60 antigen). (d) Nuclei are segmented based on Hoechst 3334
dilation of segmented nuclei and application of size and nuclear stai
1-60-positive cells by overlaying nuclear segmentation image with
determined on the basis of FITC intensity. TRA-1-60-positive cells a
hESC numbers per colony and TRA-1-60-positive cells per colony are
image of cells positive for TRA-1-60. (j) Resulting measures extracData from four fields were acquired from each well using a
4x objective (representing 46% of the total well area) for
nuclear staining (Hoechst 33342) and TRA-1-60 (FITC)
(Figs. 1a, b, and c). Automated image analysis software
was then used to extract the multivariate data from the
acquired colony images. First, fluorescence of the nuclei
(Fig. 1b) was used to identify cells in the image, a process
known as segmentation, followed by erosion of pixels
identified at the edge of each nuclei in the image to
minimize overlapping of closely positioned nuclei (Fig. 1d).
Hoechst 33342 also stained nuclei of the feeder cells
present. To exclude feeder cells from images, all of the
segmented objects in the image were expanded (dilated).
This leads to merging of hESC nuclei within a colony as
they are positioned closely together. The resulting objects
in the image consisted of larger objects representing
hESC colonies and smaller objects representing dilated
feeder cell nuclei (Fig. 1e). The area of dilated objects and
intensity of Hoechst 33342 staining (hESC nuclei stain
brighter than feeder cells) were used as criteria to reject
feeders and leave only segmented hESC colonies in the
images for further analysis (Fig. 1f). To determine the
percentage of TRA-1-60-positive hESCs in each field, the
segmentation of the individual nuclei (as shown in Fig. 1d)
was used as a mask over the TRA-1-60 image (“nuclear
masking,” Fig. 1g). This ensures unambiguous scoring of
antibody staining in an individual cell. The cells were
assessed as positive for TRA-1-60 if the intensity of FITC
signal was higher than the threshold determined by the
negative control on each plate (Fig. 1h). After filtering out
feeders from the image, the proportion of hESCs positive for
TRA-1-60 was calculated by dividing the number of hESCs
positive for TRA-1-60 by the total number of hESCs per field.
This calculation was necessary to circumvent false positive
results that could arise as a consequence of the changes in
cell numbers alone. Apart from number of hESCs and
percentage of TRA-1-60 positive cells per colony, various
other parameters were measured, including number of
colonies per well, colony area, intensity of fluorescence of
Hoechst 33342 nuclear staining (average intensity of fluo-
rescence over the segmented area), and form factor (a
description of two-dimensional shape, calculated as the ratio
of the least diameter of the object to the largest where a
perfectly circular object would have the maximum value
of 1) (Figs. 1i and j).
Treatment of Shef4 cells with all-trans retinoic acid for
5 days reduced the percentage of TRA-1-60-expressing cells
to less than 25%, similar to previously reported studies
(Draper et al., 2002). All-trans retinoic acid-treated and
control cells showed significant differences in most para-
meters measured (Supplementary Table 1), reflecting the
changes in morphology of hESC colonies that accompanymated image acquisition of four fields in each of the wells of a
f the cells) and (c) FITC fluorescence (for antibody against the
2 fluorescence. (e, f) Elimination of feeder cells from images by
ning intensity as criteria for exclusion. (g) Identification of TRA-
the image of TRA-1-60 staining. (h) TRA-1-60-positive cells are
re indicated in red and negative ones in blue. (i) The data for
obtained by overlaying the colony segmentation image with the
ted from images.
106 I. Barbaric et al.differentiation. The Z′ factor (a parameter assessing the
quality of the assay (Zhang et al., 1999)) for the percentage
of positive cells in replicate plates was N0.5, indicating our
assay was robust. We then applied it to screening a library of
small molecules.High-content screen on hESCs
Our primary screen on hESCs involved testing 1040 diverse
compounds from two commercial libraries: 80 compounds
from a kinase inhibitor library and 960 compounds from
107Human embryonic stem cellthe Prestwick chemical library enriched with marketed
drugs (Supplementary Table 2). All compounds were tested
in triplicate. Kinase inhibitors were tested at a commonly
used concentration of 10 µM, whereas compounds from
the Prestwick chemical library were tested at 2.5 µg/ml
(∼5 µM). Cell numbers were used to assess cell viability on
treatment with a compound. Low cell numbers in replicate
wells (less than 40% of the control value) were taken as an
indication of cytotoxicity and such compounds were not
pursued further in this study. After this filtering step, a 50%
reduction in proportion of TRA-1-60-positive cells was used
as the criterion for identifying compounds that induce
differentiation.
We obtained 44 hits in the primary screen, with 28
compounds that decreased the proportion of TRA-1-60-
positive cells below 50% of the control value and 16
compounds that increased cell numbers 50% above the
control (Fig. 2a). Among the 28 hits that induced differen-
tiation was all-trans retinoic acid, which is included in
the Prestwick library, providing conformation of the robust-
ness of our screen. A significant proportion of hits that
caused differentiation of hESCs belonged to the steroid
class of compounds (13 steroids were among the 28 hit
compounds) (Fig. 2b), although steroids made up only 4.3%
of the compounds tested. Among the compounds that
increased hESC numbers, kinase inhibitors were the most
common (4 kinase inhibitors out of 16 hits) (Fig. 2c), although
they made up only 7.7% of the total number of compounds
tested.
To verify hits from the primary screen, compounds were
retested on Shef4 hESCs. Retesting the hits several times
confirmed 17 compounds that decreased TRA-1-60 expres-
sion (Supplementary Table 3) and 5 compounds that
increased cell numbers. Of these, 4 were kinase inhibitors,
Y-27632, HA1077, HA1004, and H-89, and they were also the
most potent among the compounds that increased cell
numbers in the primary screen. The fifth compound was a
potassium channel opener used as an antihypertensive drug,
pinacidil (N-cyano-N′-4-pyridinyl-N″-(1,2,2-trimethylpropyl)
guanidine) (Petersen et al., 1978; Arrigoni-Martelli et al.,
1980) (Fig. 2d).Differentiation-inducing effects of hits
The hits that reduced TRA-1-60 marker expression in the
primary screen were mainly corticosteroid drugs, and someFigure 2 Results of the primary screen on hESCs. (a) Layout of pr
differentiation or increase cell numbers. One thousand forty compou
that induced differentiation (∼1.8% of total) and 16 were hits that
significant enrichment of steroids among the hits that induced differ
compounds that increased cell numbers. (d) Effect of compounds
triplicate for 1040 compounds tested. Five circled outliers are ki
potassium channel opener pinacidil. (e–j) Comparison of informat
additional information obtained from a high-content, high-through
(f) number of cells, (g) number of colonies, (h) colony area, (i) int
form factor. Results shown are mean of triplicates±SEM. (k) Repre
vehicle control (upper panel) on hESC numbers and colony appeara
33342.of these compounds were structural analogues of one
another— e.g., prednisolone and 6-alpha methylpredniso-
lone. Apart from reduced TRA-1-60 expression (Fig. 2e) and a
reduction in cell numbers (Fig. 2f), high-content data
obtained in our primary screen indicated that steroid
treatment gave rise to a distinct morphology of hESC
colonies. For example, although the number of colonies
was not significantly different from the control (Fig. 2g),
steroid-treated cells were densely packed into small colo-
nies, and this was reflected in a smaller colony area (Fig. 2h)
as well as increased intensity levels of Hoechst 33342 nuclear
staining (Fig. 2i). Furthermore, the steroid hits caused an
increase in the form factor of colonies (Fig. 2j), indicating
that the Shef4-steroid-treated colonies adopted a more
circular morphology (Fig. 2k).
We selected four steroid hits from the primary screen,
betamethasone, dexamethasone, prednisolone, and 6-alpha
methylprednisolone, for follow-up analysis. First,wevalidated
the effects of these compounds on the loss of pluripotency
using additional markers. Treated hESCs showed a dose-
dependent decrease of OCT4 levels (Fig. 3a and data not
shown).We also quantified the expression of SSEA3, TRA-1-60,
and OCT4 using flow cytometry. Steroids induced significant
down-regulation of all threemarkers (Fig. 3b). However, some
cells still retained expression of pluripotency markers after
7 days of treatment, indicating that steroid-treated cultures
consist of a heterogeneous population of differentiated and
pluripotent cells. To further characterize the differentiated
phenotype of these cells, RT-PCR analysis was performed for
a variety of lineage-specific markers, including MIXL, MSX1,
EOMES, CDX2, CXCR4, SOX7, PAX6, and HASH. Increased
expression was seen for transcripts of trophoblast-associated
factors, EOMES and CDX2, as well as mesodermalmarkersMIXL
and MSX1 (Fig. 3c).Compounds that increased hESC numbers
Among the compounds that increased hESC numbers in the
primary screen were kinase inhibitors Y-27632, HA1077,
HA1004, and H-89, and the potassium channel opener
pinacidil. We analyzed pinacidil in more detail, as it has
not been reported to have effects on hESCs. We tested its
effect on growth of hESC lines Shef4, Shef5, Shef6, Shef7,
and H7S14 and observed consistent increase of hESC numbers
in all of the lines tested, indicating that the effect is not cell
line specific (data not shown). Furthermore, a markedimary screen on hESCs for identifying compounds that promote
nds were screened and 44 hits identified. Twenty-eight were hits
increased cell numbers (∼1.5% of total). (b) Pie chart shows a
entiation. (c) Kinase inhibitors were overrepresented among the
on hESC numbers. Each dot on the graph represents mean of
nase inhibitors (Y-27632, HA1077, H-89, and HA1004) and the
ion obtained from a classical high-throughput assay (e,f) with
put assay (g–j) for steroid hits: (e) %TRA-1-60-positive cells,
ensity levels of Hoechst 33342 nuclear staining, and (j) colony
sentative images of the effects of steroids (lower panel) versus
nce (inset) in the primary screen. Cells are stained for Hoechst
108 I. Barbaric et al.
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culture conditions on Matrigel, either in feeder-conditioned
medium or in chemically defined mTESR medium (Fig. 4a).
Pinacidil exhibited a dose-dependent effect on growth of
Shef4 hESCs (Fig. 4b). At Day 3 after plating and treatment,
the number of cells was already 3.5 times higher in wells with
100 µM pinacidil compared to the control (P=7.5×10-6,
Student's t test). Even at the 12.5 µM concentration, this
effect was still significant (1.95-fold more cells than control,
P=4×10-5, Student's t test).
Given that pinacidil had a marked effect on cell numbers
as early as 2 days after seeding, we postulated that pinacidil
increases cell numbers by promoting survival or attachment
of hESCs at the time of plating rather than affecting
proliferation. To examine this further, we monitored the
attachment of cells on treatment with 100 and 10 µM
pinacidil. Shef4 hESCs that expressed GFP were plated in
96-well plates on feeder cells and after removing unattached
cells by gentle washing the attached cells were imaged at 1,
3, and 6 h after plating. The appearance of cells plated in the
presence of 100 µM pinacidil was already markedly different
1 h after plating. They appeared more flattened out
compared to the more rounded control cells. This difference
became even more pronounced at later time points (Fig. 4c).
Both the number of attached cells and the cell area from the
images were quantified. A significant increase in the number
of attached cells was already observed 3 h after plating in
wells with 100 µM pinacidil (Fig. 4d). Quantifying the average
size (area) of attached cells revealed a significant increase at
all three time points for 100 µM pinacidil and at 6 h for 10 µM
pinacidil (Fig. 4e). This indicated that pinacidil promotes
attachment of hESCs. The higher number and better attach-
ment of cells in pinacidil-treated samples could be due to a
higher number of hESCs surviving dissociation to single cells.
Thus, we assessed whether pinacidil reduces apoptosis by
staining cells for annexin V. Shef4 hESCs were dissociated
using trypsin and incubated in nonadhesive petri dishes
for 4 h with or without pinacidil. Control cells showed a
progressive increase in the percentage of annexin V-positive
cells over time, whereas this increase in pinacidil-treated
cells occurred at a much slower rate (Fig. 4f), suggesting that
pinacidil prevents apoptosis of dissociated hESCs.
To monitor further the differences in behavior of single
hESCs in pinacidil-containing media we used time-lapse
microscopy. Shef4 cells were filmed for 72 h from the time of
seeding in either 0.1% DMSO or 100 µM pinacidil (Supple-
mentary Fig. S2a). Tracking of individual cells and analysis of
their genealogies (Glauche et al., 2009) (Supplementary
Fig. S2b) suggested that the majority of hESCs plated under
control conditions died after seeding, whereas pinacidil
significantly improved survival rate of hESCs (Supplementary
Fig. S2c). However, the time between cell divisions was not
significantly altered in pinacidil-treated cells, indicating
that pinacidil does not alter the cell proliferation rateFigure 3 Induction of hESC differentiation by steroids. (a) Immuno
treatment with 100 µM betamethasone or dexamethasone. (b) Typi
after 7-day treatment of Shef4 cells with 100 µM steroid compounds
analysis of lineage-specific markers after 7-day treatment of Shef4 ce
or 0.1% DMSO control.(Supplementary Fig. S2d). Thus, we concluded that pinacidil
is acting as a prosurvival factor of hESCs.
The effects of pinacidil on the pluripotency of hESCs were
further examined. Flow cytometry analysis of cell surface
markers showed continued expression of the pluripotency-
associated markers SSEA3 and TRA-1-60, whereas the
differentiation-associated marker SSEA1 was reduced in
100 µM pinacidil-treated cells (Fig. 5a). Quantitative PCR
analysis also showed an increase in expression of POU5F1
(OCT4) and NANOG in cells treated with pinacidil (Fig. 5b).
To confirm that pinacidil did not adversely affect the
differentiation capacity of hESCs, pinacidil-treated cells
were assessed by inducing embryoid body (EB) formation in
media with no FGF and supplemented with 100 µM pinacidil.
RT-PCR analysis after 15 days of EB culture showed expres-
sion of various lineage markers, indicating that the hESCs
remained capable of differentiation (Fig. 5c). Furthermore,
after eight passages in 100 µM pinacidil, cells continued to
express markers of the pluripotent state, POU5F1 (OCT4) and
NANOG, and when induced to differentiate through embryoid
body formation showed upregulation of lineage-specific
markers (Fig. 5d). Cells grown in the presence of 100 µM
pinacidil for 22 passages retained a normal karyotype (Fig. 5e).
To determine whether pinacidil exerts its effects on hESCs
through KATP channels as reported for other cells, we first
examined the expression of ABCC9 that encodes the
pinacidil-binding SUR2 subunit of KATP channels. Shef4
hESCs were sorted for the SSEA3 pluripotency marker to
eliminate spontaneously differentiated cells in culture. We
detected no expression of ABCC9 at the mRNA level (Fig. 6a).
Furthermore, the effect of pinacidil could not be blocked by
using the KATP channel blocker glibenclamide (Fig. 6b).
Finally, the effects of pinacidil on hESC numbers were not
reproduced by using the pinacidil analogue P1075, nor other
KATP channel openers for the SUR1 or SUR2 subunits
(diazoxide, nicorandil, minoxidil, cromakalim) (Fig. 6c).
Hence, our findings indicate that pinacidil promotes survival
of hESCs through mechanisms that are independent of its
effects on KATP channels.
Given the striking similarity of the effect on hESCs of
pinacidil and the Rho-kinase inhibitor Y-27632 (ROCKi), we
reasoned that pinacidil might also be inhibiting Rho-kinase
(ROCK). Indeed, pinacidil showed a dose-dependent inhibi-
tion of ROCK, with only 9% activity at 100 µM pinacidil
(Fig. 6d). Furthermore, analysis of a panel of 105 kinases
showed that pinacidil inhibited PRK2 and ROCK2 activity by
more than 90%. Pinacidil also inhibited a number of other
kinases (Fig. 6e).
To compare pinacidil with other survival compounds
uncovered in our screen, we tested their effect on hESC
growth, using compounds in a range of concentrations from 1
to 100 µM. Kinase inhibitors Y-27632, HA1077, HA1004, and
H-89 showed the highest effect at 25 µM, whereas pinacidil
showed its highest effect at 100 µM. Y-27632 was the mostcytochemistry for the OCT4 marker of pluripotency 7 days after
cal examples of flow cytometry for SSEA3, TRA-1-60, and OCT4
, 10 µM all-trans retinoic acid or 0.1% DMSO control. (c) RT-PCR
lls with 100 µM steroid compounds, 10 µM all-trans retinoic acid,
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determine whether any of the compounds could synergize,
each compound was used at its optimal concentration in
combination with each of the other compounds. No additive
effects were observed (Fig. 7b). We also tested if kinase
inhibitors Y-27632, HA1077, HA1004, and H-89 could pro-
mote initial attachment of cells as pinacidil does, and
observed an effect all of these compounds on initial cell
attachment (Fig. 7c and Supplementary Fig. S3a). No
additive effect on cell attachment was observed when
compounds were used in combinations (Supplementary
Fig. S3b).
In the light of the finding that pinacidil inhibits ROCK2, we
compared our kinase activity data obtained for pinacidil to
similar published information available for Y-27632 ROCKi
(Bain et al., 2007). Pinacidil showed some overlapping
targets with Y-27632 (Fig. 7d). Both compounds strongly
inhibited PRK2 and ROCK2. Other common targets included
MNK1, RSK1, RSK2, and AMPK. However, some of the kinases
were inhibited by pinacidil but not by Y-27632. These
included PKCζ, MNK2, BRSK2, Aurora B, Erk8, S6K1, and
CHK2. We extended this analysis using the published data for
HA1077 and H-89 (Bain et al., 2007) to compare the spectrum
of targets altered by the four compounds. Kinases were
evident that were modulated by all four compounds, for
example, PRK2, ROCK, MNK1, RSK1, and MSK1 (Fig. 7e).
Finally, given that ROCKi was the most potent of the survival
compounds uncovered in our screen, we looked for kinases
that were uniquely modulated by ROCKi compared to
pinacidil, HA1077 and H-89. There are two striking differ-
ences. S6K1 and PKBα (AKT) are both strongly inhibited by
pinacidil, HA1077, and H-89 but not by ROCKi (Fig. 7e).Discussion
In this study we have developed an image-based assay for
analysis of the hESC colony phenotype and have applied it to
screening chemical libraries for compounds that can influ-
ence the behavior of hESCs. A key feature of our assay is an
automated system for the simultaneous quantification of
multiple features of hESC colonies. This includes determining
the number of cells per colony, the number of colonies per
well, the fluorescence intensity of nuclear staining, and the
percentage of cells in the colony expressing a marker of
pluripotency, as well as measuring the colony area and
shape. These parameters are important for assessing changes
in hESC fate on compound treatment. For example, colony
number is an indicator of cell survival rate at the time of
seeding, whereas cell number per colony reflects theFigure 4 Effect of pinacidil on Shef4 hES cell numbers. (a) An eq
Matrigel-coated 12-well plates, in mTESR medium supplemented wit
Two days after initial exposure to pinacidil, there was a marked inc
(b) Growth curves of Shef4 cells in different concentrations of pin
triplicate±SD. (c) Appearance of Shef4-GFP cells 1 and 6 h after pla
wells had more cells and cells seemed more flattened out compared
of pinacidil by counting attached cells at various times after platin
t test. (e) Quantifying cell area of pinacidil-treated cells. Results are
(f) Annexin V staining in dissociated Shef4 cells exposed to 100 µM pin
±SD. *Pb0.05, **Pb0.005, Student's t test.proliferative capacity of the cells. Furthermore, colony
shape and cell density within a colony can change on
differentiation. Such parameters provide indicators that
complement the use of specific markers such as TRA-1-60
surface expression, which we used to monitor cell differen-
tiation. This type of analysis was previously limited to
manual analysis on a low-throughput level. Our primary
screen was, thus, fundamentally different from previous
screens on hESCs as the combined readouts from our assay
could assess potential multiple effects of a compound on
hESC colony phenotype in an automated and quantifiable
manner.
By using this image-based high-content assay we screened
1040 compounds that were compiled from two commercial
sources. We included a library of kinase inhibitors in our
screen because kinases are known to control a wide variety
of cellular processes by regulating signaling pathways
through phosphorylation of target proteins (Cohen, 2002).
The Prestwick library was enriched with marketed drugs that
were diverse both in structure and in pharmacology. We
identified 22 hits in our screen—17 that induced differenti-
ation and 5 that increased hESC numbers.
Differentiation-inducing compounds were identified in
the primary screen on the basis of reduced expression of the
TRA-1-60 marker of pluripotency. Corticosteroid compounds
were the predominate class of molecules to have this effect.
Corticosteroids normally exert their function through binding
of steroid hormone receptors, which initiates a cascade of
signaling events that result in transcriptional control of
target genes (Lowenberg et al., 2008). Treatment of cells
with steroids induced increased expression of trophoblast
and mesoderm lineage markers. Dexamethasone has previ-
ously been used in term villous explants to stimulate
trophoblast differentiation and maturation (Audette et al.,
2010; Ringler et al., 1989) as well as to promote osteoblast
differentiation from mESCs (Buttery et al., 2001). By
promoting trophoblast and mesodermal differentiation
programs, steroids should provide useful tools for lineage
priming of hESCs.
Four of the five compounds identified to enhance the
growth of hESCs were kinase inhibitors. The fifth compound,
pinacidil, is a known agonist of ATP-sensitive potassium
channels (KATP) (Petersen et al., 1978; Arrigoni-Martelli et
al., 1980; Arena and Kass, 1989), and has not previously been
linked to ESC growth. KATP channels are expressed in a wide
variety of excitable cells in which they couple the energy
state of the cell to its membrane potential (Ashcroft and
Ashcroft, 1990). However, we could not detect the expres-
sion of the pinacidil-binding subunit of KATP channels in
undifferentiated hESCs, while other KATP channel agonistsuivalent number of Shef4 cells (50 000 cells) were seeded onto
h either 0.1% DMSO (left panel) or 100 µM pinacidil (right panel).
rease in hESC numbers. Nuclei are stained with Hoechst 33342.
acidil added at the time of plating. Values shown are mean of
ting in pinacidil-containing media. The 100 µM pinacidil-treated
to the control. (d) Monitoring cell attachment in the presence
g. Results are mean of six replicates±SD. ***Pb0.001, Student's
mean of six replicates±SD. *Pb0.05, ***Pb0.001, Student's t test.
acidil for various lengths of time. Results are mean of duplicates
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not due to the dose of pinacidil we used as it is commonly
used at 100 µM in cell-based studies and its effects at this
concentration can be blocked by the KATP channel antagonist
glibenclamide (Malhi et al., 2000; Okuyama et al., 1998).
However, glibenclamide did not inhibit the ability of
pinacidil to promote hESC survival. This strongly suggested
that pinacidil promotes hESC survival independently of its
action on KATP channels. Indeed, we showed that pinacidil
inhibits a number of kinases, such as Rho-kinase, which is
known for its role in mediating hESC survival (Watanabe et
al., 2007; Damoiseaux et al., 2009).
The reduction in the death rate among dissociated hESC
by pinacidil may have major implications for many down-
stream applications of these cells. An emerging feature of
hESC biology is their inability to survive dissociation to single
cells. The practical implication of this is that hESCs are
commonly passaged as clumps to increase their chance of
survival. However, this makes protocols for culturing and
differentiation less robust, as colony size and spatial
distribution of colonies can affect signaling pathways in
ESCs (Peerani et al., 2009). By using time-lapse imaging we
showed that pinacidil increases the survival rate of single
hESCs without leading to the formation of multicellular
clumps. Increased cell area of pinacidil-treated cells early on
plating raises the possibility that pinacidil is modulating hESC
survival through improved cell attachment. Although Y-
27632 ROCKi is often used in the stem cell field to promote
survival of hESCs, it is not an approved drug, and, therefore,
not compatible with Good Manufacturing Practice for clinical
use of hESCs. Pinacidil, which has been approved by the FDA
for clinical use, would overcome these problems.
Apart from their application in promoting hESC survival,
the compounds uncovered in our screen also present tools for
dissecting molecular pathways involved in hESC death after
single cell dissociation. By examining a kinase selectivity
profile of pinacidil and comparing it with the data published
for three other survival compounds uncovered in our screen
(Y-27632, HA1077, and H-89) we identified some overlapping
and some unique kinase targets for all of these agents. All
four compounds strongly inhibited PRK2, ROCK2, RSK1,
MSK1, and RSK2. It is conceivable that overlapping targets
are responsible for shared effects of all four compounds. To
try and delineate why Y-27632 ROCKi was the most potent
compound in increasing the cell numbers, we looked for the
kinases that ROCKi modulated in a distinct way. A striking
candidate is p70 ribosomal protein S6 kinase (S6K1), that was
strongly inhibited by pinacidil, HA1077, and H-89 but not Y-
27632. Targeted deletion of S6K1 in murine ESCs led to a
slower growth rate of the cells, indicating that S6K1 has a
positive effect on cell proliferation (Kawasome et al., 1998).
Another interesting target is protein kinase B alpha (PKBα/
AKT). PKBα has a critical role in promoting cell survival,Figure 5 Effect of pinacidil on hESC pluripotency. (a) Flow cytom
presence of 100 µM pinacidil for 5 days. (b) Quantitative PCR analysis
Results shown are mean of duplicate±SEM. (c) RT-PCR analysis of em
control cells. (d) RT-PCR analysis of cells grown for 8 passages in the
lanes), and after differentiation of these cells in embryoid bodies (r
passages in 100 µM pinacidil.proliferation, and growth. Ablation of PKBα activity impaired
cell proliferation (Skeen et al., 2006), whereas the over-
expression of constitutively activated PKBα resulted in a
malignant phenotype of NIH3T3 cells (Sun et al., 2001).
Finally, constitutively activated PKBα sufficiently main-
tained pluripotency in mouse and primate ESCs (Watanabe
et al., 2006). Thus, it is conceivable that inhibition of S6K1
and PKBα by pinacidil, HA1077, and H-89 lessens their
potency in increasing cell numbers compared to Y-27632
ROCKi which does not inhibit these targets.
The methods described here should facilitate the use of
hESCs in a wide variety of quantitative assays from drug
screening to the investigation of basic cellular processes.
Understanding pathways involved in hESC survival will have a
major impact for optimization of culture conditions thatwould
enable efficient expansion of hESCs on a large scale and relieve
selective pressure currently present in hESC cultures that
results in the appearance of genetically abnormal cells after a
prolonged period of growth and expansion in vitro (Draper et
al., 2004; Baker et al., 2007). Finally, elucidation of mechan-
isms of hESC survival will be important for eliminating the risk
of tumor formation if hESCs are to be used in cell replacement
therapies (Blum and Benvenisty, 2008). The use of image-
based multivariate quantitative cellular assays is likely to play
an increasingly important role in the investigation of the basic




Human ESC lines Shef4, Shef5, Shef6, and Shef7 were
provided by Professor Harry Moore, University of Sheffield
(Aflatoonian et al., 2010). The H7 cell line was obtained from
Dr. James Thomson, University of Wisconsin. The H7S14
subline was isolated at the University of Sheffield, 15
passages after original derivation. The Shef4-GFP line was
created using pCAGeGFP vector as previously described
(Liew et al., 2007). HESC lines were maintained on
mitotically inactivated mouse embryonic fibroblasts as
previously described (Liew et al., 2007).
Compound libraries and chemicals
Compounds used in the primary screen were assembled from
two commercial libraries: (i) 80 protein kinase inhibitors
used were from a Protein Kinase Inhibitor library (BIOMOL,
Enzo Life Sciences, Exeter, UK; http://www.biomol.com)
and (ii) 960 compounds were from the Prestwick Chemical
Library (Prestwick Chemical, Illkirch, France; http://www.
prestwickchemical.com), enriched with marketed drugs. Alletry analysis of cell surface markers after culturing cells in the
for POU5F1 (OCT4), NANOG, and SOX2 markers of pluripotency.
bryoid bodies induced in the presence of 100 µM pinacidil versus
presence of 0.1% DMSO vehicle control or 100 µM pinacidil (left
ight lanes). (e) Representative karyotype of Shef4 cells after 22
115Human embryonic stem cellof the compounds used in the screen are listed in Supple-
mentary Table 2. All-trans retinoic acid, pinacidil monohy-
drate, glibenclamide, cromakalim, prednisolone, 6-alphamethylprednisolone, betamethasone, and dexamethasone
were purchased from Sigma-Aldrich. P1075 was purchased
from Tocris Bioscience (Bristol, UK).
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Shef4 hESCs were dissociated to single cells using a 1:3
solution of Accutase (Millipore) in PBS. Six thousand cells
were seeded in 96-well plates on feeders in the presence of
compounds (10 µM for compounds from Protein Kinase
Inhibitor library and 2.5 µg/ml (∼5 µM) for compounds
from the Prestwick Chemical library. Each compound was
assessed in triplicate wells. Control wells containing 0.1%
DMSO as well as 10 µM all-trans retinoic acid were included
on each plate. After 5 days, cells were fixed with 4%
paraformaldehyde. Cells were incubated with TRA-1-60
(1:10) (Andrews et al., 1984) primary antibody followed by
incubation with the FITC-conjugated secondary antibody
(goat anti-mouse IgG+M, Invitrogen). Nuclei were counter-
stained with 10 µg/ml Hoechst 33342 (Invitrogen). Each
plate included control wells that were stained with Hoechst
33342 and secondary antibody only, to determine the back-
ground fluorescence levels of secondary antibody. Images of
stained cells were acquired using an automated microscopy
platform (InCell Analyzer 1000, GE Healthcare). Images
were analyzed using Developer Toolbox 1.7 software (GE
Healthcare).
The Z′ factor is a dimensionless parameter used to
evaluate the performance of a screening assay (Zhang et
al., 1999). To calculate the Z′ factor, 30 wells of a 96-well
plate were treated with 0.1% DMSO as negative control, and
30 wells were treated with 10 µM all-trans retinoic acid as
positive control. The Z′ factor was calculated using the
following formula: 1 – [(3×SD (DMSO control)+3×SD (all-
trans retinoic acid control)/(mean (DMSO control) – mean
(all-trans retinoic acid control)] (Zhang et al., 1999).
Immunocytochemistry for OCT4 protein
Cells were fixed with 4% paraformaldehyde and, after
blocking for 1 h, permeabilized with 0.1% Triton-X for 1 h
at 4 °C. Cells were then incubated with an anti-OCT4 primary
antibody (1:200, Oct4A, rabbit monoclonal, C52G3, Cell
Signaling Technology). Secondary antibody used was Dylight-
488-conjugated anti-rabbit IgG antibody (1:100, Stratech
Scientific). Nuclei were counterstained with 10 µg/ml
Hoechst 33342 (Invitrogen).
Cell growth analysis
For growth curve analysis, dissociated Shef4 hESCs were
plated in 96-well plates on feeders as described above. Cells
were fixed with 4% paraformaldehyde at various times afterFigure 6 Pinacidil action on hESC numbers is KATP channel-indepe
panel). Human heart cDNA was used as a positive control. The GAPD
(lower panel). (b) KATP channel blocker glibenclamide at 100 µM did n
numbers. Results are mean of six replicates±SD. (c) Several oth
cromakalim, diazoxanide) were tested on hESCs but did not show eff
six replicates±SD. (d) Pinacidil inhibits Rho-kinase in a dose-depende
Results are presented as the percentage activity in the presence o
duplicate measurements±SD). Kinases inhibited by pinacidil to less
inhibited by 10–50% are indicated in blue.seeding and stained with 10 µg/ml Hoechst 33342 (Invitro-
gen). Plates were imaged using the InCell Analyzer 1000 (GE
Healthcare) and images were analyzed for number of hESCs
using Developer Toolbox 1.7 software (GE Healthcare) as
described above.
Flow cytometry and cell sorting
For the analysis of cell-surface markers, cells were harvested
using trypsin and resuspended in wash buffer (PBS supple-
mented with 10% fetal calf serum). Staining for OCT4 was
performed on cells fixed with 4% paraformaldehyde and
permeabilized with 0.3% Triton-X for 15 min at RT. Cells
(5×105) were incubated with a primary antibody (1:10,
SSEA3, TRA-1-60, and SSEA-1; 1:200 Oct4A, rabbit monoclo-
nal, C52G3, Cell Signaling Technology) for 1 h. After washing
three times with wash buffer, in the case of SSEA3, TRA-1-60,
and SSEA-1, cells were labeled with FITC-conjugated goat
anti-mouse antibody (1:150, Invitrogen) and in the case of
OCT4 with Dylight-488-conjugated anti-rabbit IgG antibody
(1:100, Stratech Scientific) for 1 h. This was followed by
washing the cells three times with wash buffer and analyzing
cell fluorescence on a CyAnADP O2 flow cytometer (Dako).
The gate for FITC-positive cells was set using control cells
that were incubated with secondary antibody only. Cell
sorting for SSEA3-positive cells was achieved with 107 cells in
a MoFlo Cell Sorter (Dako).
Cell attachment assay
Shef4-GFP cells were dissociated to single cells and 5000
cells were seeded in 96-well plates on feeders in the
presence of test compounds or control. At various time
points after plating the cells, media were removed and cells
were washed with PBS to remove unattached cells. Cells
were imaged for GFP fluorescence using the InCell Analyzer
1000. Developer Toolbox 1.7 software was used to determine
the number of cells per well and the cell area.
Annexin V apoptosis assay
Shef4 hESCs were dissociated to single cells with trypsin and
106 cells were seeded onto 10-cm-diameter nonadhesive
dishes (Sterilin) in complete hESC medium supplemented
with 0.1% (v/v) DMSO (control) or 100 µM pinacidil. Cells
were harvested at 1, 2, 3, and 4 h after seeding, and
analyzed for apoptosis using human annexin V:FITC conju-
gate according to manufacturer's protocol (Invitrogen).ndent. (a) RT-PCR analysis of ABCC9 expression in hESCs (upper
H housekeeping gene was used as a positive control for RT-PCR
ot diminish effect of various concentrations of pinacidil on hESC
er known KATP channel openers (P1075, minoxidil, nicorandil,
ects similar to those of pinacidil (black bar). Results are mean of
nt manner. (e) The specificity of pinacidil among protein kinases.
f 100 µM pinacidil compared with control incubations (mean of
than 10% of control activity are indicated in red, while those
117Human embryonic stem cell
118 I. Barbaric et al.Briefly, 105 cells were harvested, washed once with PBS and
once with binding buffer (10 mM HEPES, 140 mM NaCl,
2.5 mM CaCl2, pH 7.4), and then incubated with 20 µl of
annexin V-FITC for 20 min at room temperature, in the dark.
Propidium iodide (10 µg/ml) (Sigma-Aldrich) was added to
each sample followed by analysis of cell fluorescence on a
CyAnADP O2 flow cytometer (DakoCytomation, Glostrup,
Denmark).
Feeder-free cultures
For assaying effects of pinacidil under feeder-free condi-
tions, hESC colonies were manually picked and transferred to
plates coated in Matrigel (BD Biosciences). Media used in this
assay were either feeder-conditioned media supplemented
with 8 ng/ml bFGF (Invitrogen), or mTESR Maintenance
Medium (StemCell Technologies). For single cell cultures,
hESC colonies were dissociated to single cells using Accutase
(Milipore) as described above.
Embryoid body differentiation
Shef4 hESCs were treated with 1% collagenase type IV
(Invitrogen) for 10–20 min at 37 °C and scraped off the flask.
The detached cells were washed once in media and
transferred into nonadhesive petri dishes (Sterilin) and
incubated at 37 °C and 5% CO2. The differentiation media
used were the same as media for hESC maintenance but
without bFGF.
RNA extraction, reverse transcriptase
reaction, PCR, and quantitative PCR
Total RNA was extracted using TRIzol Reagent (Invitrogen)
according to the manufacturer's instructions. First-strand
cDNA was synthesized SuperScript II reverse transcriptase
(Invitrogen) or RevertAid H Minus MMuLV Reverse Transcrip-
tase (Fermentas, York, UK), according to the manufacturer's
instructions. PCR was performed using gene-specific primers
and Taq polymerase (Invitrogen), in 25 µl PCR, according to
manufacturer's instructions. Human heart cDNA that was
used as a control for ABCC9 amplification was purchased
from PrimerDesign (Southampton, UK). For qPCR, 1 µl of
cDNA template in a 20-µl reaction volume containing 2X SYBR
Green JumpStart Taq Ready Master Mix (Sigma) and 4 pmol of
each of the forward and reverse primer was used. Reactions
were run on an iCycler iQ (Bio-Rad Laboratories). Each sample
was tested in triplicate. The expression of GAPDH was used to
normalize the samples. Sequences of primers were obtained
either from published studies or selected from target
sequences using the Primer3 program (http://frodo.wi.mit.
edu/primer3) and are listed in Supplementary Table 4.Figure 7 Comparison of activity and molecular targets of survival c
compounds tested on Shef4 hESC numbers after 5 days of growth
triplicate±SD. (b) Administration of survival compounds in combina
of triplicate±SD. (c) Representative images of Shef4-GFP 6 h after pl
protein kinases that are inhibited by pinacidil and Y-27632 ROCKi.
inhibited by pinacidil only are in the top left quadrant. (e) A heat map
kinases in the presence of pinacidil, Y-27632, HA1077, and H-89.Karyotyping
The karyotype analysis was performed using standard G-
banding techniques. Cells cultured in a T25 flask were
treated with 0.1 µg/ml Colcemid (Invitrogen) for up to 4 h,
followed by dissociation with 0.25% trypsin/versene (Gibco).
The cells were pelleted via centrifugation and resuspended
in prewarmed 0.0375 M KCl hypotonic solution and incubated
for 10 min. Following centrifugation the cells were resus-
pended in fixative (3:1 methanol:acetic acid). Meta-
phase spreads were prepared on glass microscope slides
and G-banded by brief exposure to trypsin and stained
with 4:1 Gurr's/Leishmann's stain (Sigma). A minimum of 10
metaphase spreads were analyzed and a further 20 counted.
Protein kinase activity assays
Examinations of the dose-dependent effect of pinacidil on
ROCK2 kinase as well as the screen of pinacidil activity on a
panel of 105 kinases were performed by National Centre for
Protein Kinase Profiling, MRC Protein Phosphorylation Unit,
Dundee (www.kinase-screen.mrc.ac.uk), as previously de-
scribed (Bain et al., 2007).
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